Vaxart Inc banner

Vaxart Inc
NASDAQ:VXRT

Watchlist Manager
Vaxart Inc Logo
Vaxart Inc
NASDAQ:VXRT
Watchlist
Price: 0.7875 USD 2.27%
Market Cap: $189.1m

During the last 3 months Vaxart Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 113% over this period (open performance analysis).

The last transaction was made on Nov 17, 2025 by Watson W. Mark , who bought 6.2k USD worth of VXRT shares.

Last Transactions:
Watson W. Mark
$+6.2k
Heron Elaine J
$+9.1k
Finney Kevin
$+17.5k
Finney Kevin
$+9.8k
Watson W. Mark
$+4.1k
Lo Steven
$+49k
Watson W. Mark
$+13.6k
Watson W. Mark
$+15.1k
Ahmad Fuad
$+16.1k
Yedid Robert A.
$-9k
Echerd Margaret
$-28.8k
Echerd Margaret
$-16.4k
Echerd Margaret
$-18k
Tucker Sean
$-42.6k
Echerd Margaret
$-14.4k
Echerd Margaret
$-14.4k
Yedid Robert A.
$-86.1k
Echerd Margaret
$-380.4k
Latour Wouter
$-712.8k
Latour Wouter
$-653.9k
Latour Wouter
$-906.5k
Latour Wouter
$-2.1m
Armistice Capital, Llc
$-77.8m
Armistice Capital, Llc
$-189.2m
Boyd Steven
$-1.1m
Boyd Steven
$-2.2m
Boyd Steven
$-548k
Boyd Steven
$-522k
Armistice Capital, Llc
$-572k
Armistice Capital, Llc
$-1.2m
Armistice Capital, Llc
$-3.7m
Armistice Capital, Llc
$-1.9m
View All Transactions

During the last 3 months Vaxart Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 113% over this period (open performance analysis).

The last transaction was made on Nov 17, 2025 by Watson W. Mark , who bought 6.2k USD worth of VXRT shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
2
15.3k USD
6-9
months
2
31.4k USD
9-12
months
1
49k USD

Vaxart Inc
Insider Trading Chart

Vaxart Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Vaxart Inc
Last Insider Transactions

Global
Insiders Monitor

Vaxart Inc
Glance View

Market Cap
189.1m USD
Industry
Biotechnology

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. The company is headquartered in South San Francisco, California and currently employs 110 full-time employees. Its programs include tablet vaccines designed to protect against coronavirus, norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV). The Company’s product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection. The firm is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus.

VXRT Intrinsic Value
1.5573 USD
Undervaluation 49%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett